Investor Relations

Press Release

AAC Holdings, Inc. Reports Second Quarter 2018 Results

Reaffirms 2018 Annual Guidance

Company Release - 8/1/2018 4:34 PM ET

BRENTWOOD, Tenn., Aug. 1, 2018 /PRNewswire/ -- AAC Holdings, Inc. (NYSE: AAC) today announced financial results for the second quarter ended June 30, 2018 and reiterates its previously issued full year 2018 guidance.

Second Quarter 2018 Operational and Financial Highlights: 
(All comparisons are to the comparable prior-year period, unless otherwise noted)

  • Total revenue increased 27% to $86.8 million on a comparable accounting basis (increased 11% as reported)
  • Average daily inpatient revenue (ADR) increased 12% to $841
  • Total average daily census (ADC) increased to 1,157 compared with 961
  • Outpatient visits increased 230% to 51,019
  • Net loss attributable to AAC Holdings, Inc. common stockholders was $3.0 million, or $(0.12) per diluted common share
  • Adjusted EBITDA increased 2% to $14.8 million (see non-GAAP reconciliation herein)
  • Adjusted earnings per diluted common share was $0.09 (see non-GAAP reconciliation herein)

"We are pleased with the progress we have made this year as we continue to execute to plan and make strides in transforming our sales and marketing team, including opening a new admissions center and bringing on new senior leadership," said Michael Cartwright, Chairman and Chief Executive Officer of AAC Holdings, Inc. "Operations during the quarter remained very strong with the integration of AdCare going well and the continued improvements in cash collections. We remain focused on our sales and marketing efforts and feel confident we will meet our annual guidance with continued momentum entering into 2019."

Adoption of New Revenue Recognition Standard

In May 2014, the FASB issued Accounting Standards Codification Topic 606, "Revenue from Contracts with Customers" (ASC Topic 606), a replacement of Revenue Recognition ASC Topic 605. The Company adopted ASC Topic 606 on January 1, 2018 using the modified retrospective approach. Under ASC Topic 606, the provision for doubtful accounts, which historically was reported as an operating expense, is now reported as a direct reduction to revenue effective January 1, 2018. This change in presentation reduced revenues and operating expenses by the same amount and did not have an effect on net income or earnings per share. As the Company adopted ASC Topic 606 using the modified retrospective approach, prior year periods were not recast and as such, revenues as reported for those periods are not comparable to the current year presentation. For purposes of this release, we have applied our adoption of ASC Topic 606 to the prior year period. We believe this allows for an accurate comparison of prior period revenue. Where we have used language such as "less the provision for doubtful accounts," this indicates a comparison of periods that reflects our adoption of ASC Topic 606.

AdCare Acquisition

On March 1, 2018, AAC acquired AdCare, Inc. and its subsidiaries ("AdCare"). AdCare offers treatment for drug and alcohol addiction and includes, among other things, a 114-bed hospital and 5 outpatient centers in Massachusetts, as well as a 59-bed residential inpatient treatment center and 2 outpatient centers in Rhode Island. AdCare was purchased for total consideration of $85.0 million, subject to adjustments.

Second Quarter 2018 Financial Results

AAC breaks down its revenues between client related revenue and non-client related revenue. Client related revenue includes: (1) inpatient treatment facility services and related professional services; (2) outpatient facility services, related professional services and sober living services; and (3) client related diagnostic services, which includes point of care drug testing and client related diagnostic laboratory services. Non-client related revenue includes marketing and diagnostic services provided to third parties as well as addiction services provided to individuals in the criminal justice system.

Total revenue on a comparable accounting basis (i.e., less the provision for doubtful accounts) increased 27% to $86.8 million compared with $68.5 million in the same period in the prior year. Total revenue as reported increased 11%.

Inpatient treatment facility revenue, on a comparable accounting basis, increased 21% to $66.7 million compared with $55.1 million in the same period in the prior year. ADR increased 12% to $841 compared with $752 in the same period in the prior year.

Outpatient and sober living facility revenue, on a comparable accounting basis, increased 60% to $9.0 million compared with $5.6 million in the same period in the prior year. Average revenue per outpatient visit (ARV) decreased 56% to $177 compared with $403 in the same period in the prior year.

Client related diagnostic services revenue, on a comparable accounting basis, increased 39% to $7.5 million compared with $5.4 million in the same period in the prior year.

Non-client related revenue, on a comparable accounting basis, increased 48% to $3.5 million compared with $2.4 million in the same period in the prior year.

Net loss attributable to AAC Holdings, Inc. common stockholders was $3.0 million, or $(0.12) per diluted common share, compared with $1.9 million, or $(0.08) per diluted common share, in the prior-year period.

Adjusted EBITDA increased 2% to $14.8 million compared with $14.5 million for the same period in the prior year. Adjusted net income attributable to AAC Holdings, Inc. common stockholders decreased to $2.2 million, or $0.09 per diluted common share, compared with $6.1 million, or $0.26 per diluted common share, for the same period in the prior year. Adjusted EBITDA, adjusted net income attributable to AAC Holdings, Inc. common stockholders and adjusted earnings per diluted common share are non-GAAP financial measures. Tables reconciling these non-GAAP measures to the most directly comparable GAAP measures are included at the end of this release.

Balance Sheet and Cash Flows

As of June 30, 2018, AAC Holdings' balance sheet reflected cash and cash equivalents of $11.4 million, net property and equipment of $168.4 million and total debt of $302.0 million, net of debt issuance costs of $9.4 million.

Cash flows provided by operations totaled $3.3 million and maintenance capital expenditures totaled $1.1 million for the second quarter of 2018.

2018 Outlook

AAC maintains its previously issued guidance as follows:



Full Year 2018 Guidance



(in millions, except per share data)

Total Revenues


$325 - $340

Inpatient treatment facility revenue


$262 - $266

Outpatient and sober living facility revenue


$40 - $46

Client related diagnostic services revenue


$12 - $15

Non-client related revenue


$11 - $13




Adjusted EBITDA


$68 - $72

Adjusted Earnings per Diluted Common Share


$0.75 - $0.80

The Company now expects an annual effective tax rate of 20% to 22%, down from 24% to 26%, and diluted weighted-average common shares outstanding of approximately 24.5 million for the year.

This outlook above does not include the impact of any future acquisitions, transaction-related costs, litigation settlement or expenses related to legal defenses.

With respect to the "2018 Outlook" above, reconciliation of adjusted EBITDA and adjusted earnings per diluted common share guidance to the closest corresponding GAAP measure on a forward-looking basis is not available without unreasonable efforts. This inability results from the inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations. In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including de novo start-up and other expense and acquisition-related expenses. We expect these adjustments may have a potentially significant impact on future GAAP financial results.

Earnings Conference Call

The Company will host a conference call and live audio webcast on Thursday, August 2, 2018, at 10:00 a.m. CT to further discuss these results. The number to call for this interactive teleconference is 412-542-4144. A replay of the conference call will be available through August 9, 2018, by dialing 412-317-0088 and entering the replay access code, 10122876. The live audio webcast of the Company's quarterly conference call will also be available online in the Investor Relations section of the Company's website at ir.americanaddictioncenters.org.

About American Addiction Centers

American Addiction Centers is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at AmericanAddictionCenters.org or follow us on Twitter.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws.  These forward-looking statements are made only as of the date of this release.  In some cases, you can identify forward-looking statements by terms such as "anticipates," "believes," "could," "estimates," "expects," "may," "potential," "predicts," "projects," "should," "will," "would," and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these words.  Forward-looking statements may include information concerning AAC Holdings, Inc.'s (collectively with its subsidiaries; "AAC Holdings" or the "Company") possible or assumed future results of operations, including descriptions of the Company's revenue, profitability, outlook and overall business strategy.  These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from the information contained in the forward-looking statements.  These risks, uncertainties and other factors include, without limitation: (i) our inability to effectively operate our facilities; (ii) our reliance on our sales and marketing program to continuously attract and enroll clients; (iii) a reduction in reimbursement rates (or failure to pay) by certain third-party payors for inpatient and outpatient services and point-of-care and definitive lab testing; (iv) our failure to successfully achieve growth through acquisitions and de novo projects; (v) the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of an acquisition; (vi) our failure to achieve anticipated financial results from contemplated and prior acquisitions; (vii) a disruption in our ability to perform diagnostic laboratory services; (viii) maintaining compliance with applicable regulatory authorities, licensure and permits to operate our facilities and laboratories; (ix) a disruption in our business and reputational and economic risks associated with civil claims by various parties; (x) inability to meet the covenants in our loan documents or lack of borrowing capacity; (xi) our inability to effectively integrate acquired facilities; and (xii) general economic conditions, as well as other risks discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2017, the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2018, and other filings with the Securities and Exchange Commission.  As a result of these factors, we cannot assure you that the forward-looking statements in this release will prove to be accurate.  Investors should not place undue reliance upon forward-looking statements.


 

AAC HOLDINGS, INC.


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


Unaudited


(Dollars in thousands, except per share data)



















Three Months Ended



Six Months Ended



June 30, 2018



June 30, 2017



June 30, 2018



June 30, 2017


Revenues
















Client related revenue

$

83,293



$

75,692



$

159,216



$

146,911


Non-client related revenue


3,468




2,350




6,018




4,170


Total revenues


86,761




78,042




165,234




151,081


















Operating expenses
















Salaries, wages and benefits


46,850




34,508




86,934




71,280


Client related services


8,393




6,646




16,140




13,024


Provision for doubtful accounts


366




9,496




366




16,083


Advertising and marketing


2,584




3,266




5,183




7,041


Professional fees


4,950




3,039




8,600




5,681


Other operating expenses


12,194




8,199




22,782




16,988


Rentals and leases


2,563




1,849




4,679




3,734


Litigation settlement


244







3,035





Depreciation and amortization


5,909




5,058




11,373




10,527


Acquisition-related expenses





42




305




225


Total operating expenses


84,053




72,103




159,397




144,583


Income from operations


2,708




5,939




5,837




6,498


Interest expense, net


7,893




2,846




14,602




5,580


Loss on extinguishment of debt





5,435







5,435


Other (income) expense, net


(98)




(6)




(89)




28


Loss before income tax (benefit) expense


(5,087)




(2,336)




(8,676)




(4,545)


Income tax (benefit) expense


(84)




562




(1,578)




(3)


Net loss


(5,003)




(2,898)




(7,098)




(4,542)


Less: net loss attributable to noncontrolling
interest


1,990




982




3,883




2,023


Net loss attributable to AAC Holdings, Inc.

      common stockholders

$

(3,013)



$

(1,916)



$

(3,215)



$

(2,519)


















Basic loss per common share

$

(0.12)



$

(0.08)



$

(0.13)



$

(0.11)


Diluted loss per common share

$

(0.12)



$

(0.08)



$

(0.13)



$

(0.11)


Weighted-average common shares outstanding:
















Basic


24,166,976




23,242,177




23,956,760




23,203,081


Diluted


24,166,976




23,242,177




23,956,760




23,203,081



 

 


AAC HOLDINGS, INC.


CONDENSED CONSOLIDATED BALANCE SHEETS


Unaudited


(Dollars in thousands)













June 30



December 31,




2018



2017


Assets









Current assets









Cash and cash equivalents


$

11,353



$

13,818


Accounts receivable, net of allowances



97,362




94,096


Prepaid expenses and other current assets



4,638




4,022


Total current assets



113,353




111,936


Property and equipment, net



168,373




152,548


Goodwill



197,184




134,396


Intangible assets, net



13,201




8,829


Deferred tax assets, net



9,572




8,010


Other assets



11,069




12,556


Total assets


$

512,752



$

428,275











Liabilities and Stockholders' Equity









Current liabilities









Accounts payable


$

6,613



$

4,579


Accrued and other current liabilities



30,487




27,661


Accrued litigation






23,607


Current portion of long-term debt



6,723




4,722


Total current liabilities



43,823




60,569


Long-term debt, net of current portion and debt issuance costs



295,322




196,451


Financing lease obligation, net of current portion



24,488




24,541


Other long-term liabilities



12,322




10,546


Total liabilities



375,955




292,107











Stockholders' equity



155,506




150,994


Noncontrolling interest



(18,709)




(14,826)


Total stockholders' equity including noncontrolling interest



136,797




136,168


Total liabilities and stockholders' equity


$

512,752



$

428,275


 

 

AAC HOLDINGS, INC.


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


Unaudited


(Dollars in thousands)











Six Months Ended



June 30, 2018



June 30, 2017


Cash flows (used in) provided by operating activities:








Net loss

$

(7,098)



$

(4,542)


Adjustments to reconcile net loss to net cash (used in) provided by
operating activities:








Provision for doubtful accounts


366




16,083


Depreciation and amortization


11,373




10,527


Equity compensation


2,159




4,189


Loss on extinguishment of debt





5,435


Loss on disposal of property and equipment


34





Amortization of debt issuance costs


1,357




364


Deferred income taxes


(1,562)




(582)


Changes in operating assets and liabilities:








Accounts receivable


724




(25,276)


Prepaid expenses and other assets


1,475




690


Accounts payable


(1,464)




1,286


Accrued and other current liabilities


457




932


Accrued litigation


(23,300)




(406)


Other long-term liabilities


(230)




(311)


Net cash (used in) provided by operating activities


(15,709)




8,389


Cash flows used in investing activities:








Purchase of property and equipment


(11,196)




(18,665)


Acquisition of subsidiaries


(65,185)





Net cash used in investing activities


(76,381)




(18,665)


Cash flows provided by financing activities:








Payments on 2015 Credit Facility and Deerfield Facility





(204,773)


Proceeds from 2015 Credit Facility and Deerfield Facility,
 
net of deferred financing costs





11,679


Payments on 2017 Credit Facility


(3,448)





Proceeds from 2017 Credit Facility, net of deferred financing costs


94,286




211,494


Payments on capital leases and other


(440)




(400)


Payments on AdCare Note


(250)





Payment of employee taxes for net share settlement


(523)




(895)


Net cash provided by financing activities


89,625




17,105


Net change in cash and cash equivalents


(2,465)




6,829


Cash and cash equivalents, beginning of period


13,818




3,964


Cash and cash equivalents, end of period

$

11,353



$

10,793



 

AAC HOLDINGS, INC.


OPERATING METRICS


Unaudited



















Three Months Ended



Six Months Ended



June 30, 2018



June 30, 2017



June 30, 2018



June 30, 2017


Operating Metrics:
















New admissions1


5,242




3,008




8,981




6,224


Average daily inpatient census2


872




805




823




804


Average daily sober living census3


285




156




270




155


Total average daily census


1,157




961




1,093




959


Average episode length (days)4


21




28




23




28


Average daily inpatient revenue5

$

841



$

752



$

884



$

696


Revenue per admission6

$

15,890



$

25,164



$

17,728



$

23,604


Outpatient visits7


51,019




15,463




81,332




32,013


Revenue per outpatient visit8

$

177



$

403



$

214



$

373


Client related diagnostic services9


9

%



10

%



6

%



16

%

Inpatient bed count at end of period10


1,112




1,100




1,112




1,100


Effective inpatient bed count at end of
   period11


1,108




957




1,108




957


Average effective inpatient bed utilization12


79

%



80

%



78

%



78

%


1  Represents total client admissions at our inpatient facilities for the periods presented.

2  Represents average daily client census at all of our inpatient facilities.

3  Represents average daily client census at our sober living facilities.

4  Average episode length is the consecutive number of days from admission to discharge that a client stays at an AAC inpatient facility and, when applicable, an AAC sober living facility.

5  Average daily inpatient revenue is calculated as total revenues from all of our inpatient facilities less provision for doubtful accounts during the period, divided by the product of the number of days in the period multiplied by average daily inpatient census.

Revenue per admission is calculated by dividing total client related revenue, after the provision for doubtful accounts, by new admissions.

7 Represents the total number of outpatient visits at our standalone outpatient centers during the periods presented.

8  Revenue per outpatient visit is calculated as total revenues from all of our standalone outpatient facilities, after the provision for doubtful accounts, divided by the number of outpatient visits during the period.

9  Client related diagnostic services revenue, as a percentage of client related revenue, includes point-of-care and client related diagnostic laboratory services.

10  Inpatient bed count at end of period includes all beds at inpatient facilities.

11  Effective bed count at end of period represents the number of beds for which our facilities are staffed based on planned census. 

12  Average effective inpatient bed utilization represents average daily inpatient census divided by the average effective inpatient bed count during the applicable period.

 

 


 

AAC HOLDINGS, INC.


SUPPLEMENTAL RECONCILIATION OF NON-GAAP DISCLOSURES


Unaudited


(Dollars in thousands)


Reconciliation of Adjusted EBITDA to Net Loss Attributable to AAC Holdings, Inc. Common Stockholders





















Three Months Ended



Six Months Ended




June 30, 2018



June 30, 2017



June 30, 2018



June 30, 2017


Net loss attributable to AAC Holdings, Inc.
   common stockholders


$

(3,013)



$

(1,916)



$

(3,215)



$

(2,519)


Non-GAAP Adjustments:

















Interest expense



7,893




2,846




14,602




5,580


Depreciation and amortization



5,909




5,058




11,373




10,527


Income tax benefit



(84)




562




(1,578)




(3)


Net loss attributable to noncontrolling
   interest



(1,990)




(982)




(3,883)




(2,023)


Stock-based compensation and related tax
   reimbursements



1,361




2,052




2,159




4,189


Litigation settlement and California matter
   related expense



1,201




402




4,403




561


Acquisition-related expense



24




42




453




314


De novo start-up and other expense



382




928




640




4,282


Recruitment and retention expense



715







885





Employee severance expense



384




46




1,295




789


Loss on extinguishment of debt






5,435







5,435


Facility closure operating losses and expense



1,993







2,785





Adjusted EBITDA


$

14,775



$

14,473



$

29,919



$

27,132


 

Adjusted EBITDA, adjusted net income attributable to AAC Holdings, Inc. common stockholders and adjusted diluted earnings per common share (herein collectively referred to as "Non-GAAP Disclosures") are "non-GAAP financial measures" as defined under the rules and regulations promulgated by the U.S. Securities and Exchange Commission, each of which are defined below. Management believes the Non-GAAP Disclosures provide investors with additional meaningful financial information that should be considered when assessing our underlying business performance and trends. We believe the Non-GAAP Disclosures also enhance investors' ability to compare period-to-period financial results. The Non-GAAP Disclosures should not be considered as measures of financial performance under U.S. generally accepted accounting principles ("GAAP"). The items excluded from the Non-GAAP Disclosures are significant components in understanding and assessing our financial performance and should not be considered as an alternative to net income or other financial statement items presented in the condensed consolidated financial statements. Because the Non-GAAP Disclosures are not measures determined in accordance with GAAP, the Non-GAAP Disclosures may not be comparable to other similarly titled measures of other companies. 

Management defines adjusted EBITDA as net income (loss) attributable to AAC Holdings, Inc. common stockholders adjusted for interest expense, depreciation and amortization expense, income tax benefit, net loss attributable to noncontrolling interest, stock-based compensation and related tax reimbursements, litigation settlement and California matter related expense, acquisition-related expense (which includes professional services for accounting, legal, valuation services and licensing expenses), de novo start-up and other expenses, recruitment and retention expense, employee severance expense and facility closure operating losses and expense.


 

AAC HOLDINGS, INC.


SUPPLEMENTAL RECONCILIATION OF NON-GAAP DISCLOSURES


Unaudited


(Dollars in thousands, except per share data)


Reconciliation of Adjusted Net Income Attributable to AAC Holdings, Inc. Common Stockholders to Net Loss Attributable to AAC Holdings, Inc. Common Stockholders





















Three Months Ended



Six Months Ended




June 30, 2018



June 30, 2017



June 30, 2018



June 30, 2017


Net loss attributable to AAC Holdings, Inc.
   common stockholders


$

(3,013)



$

(1,916)



$

(3,215)



$

(2,519)


Non-GAAP Adjustments:

















Litigation settlement and California matter
   related expense



1,201




402




4,403




561


Acquisition-related expense



24




42




453




314


De novo start-up and other expense



382




928




640




4,282


Recruitment and retention expense



715







885





Employee severance expense



384




46




1,295




789


Loss on extinguishment of debt






5,435







5,435


Facility closure operating losses and expense



1,993







2,785





Income tax effect of non-GAAP adjustments



496




1,158




(1,903)





Adjusted net income attributable to AAC
   Holdings, Inc. common stockholders


$

2,182



$

6,095



$

5,343



$

8,862


Weighted-average common shares outstanding -
   diluted



24,166,976




23,242,177




23,956,760




23,203,081


GAAP diluted loss per common share


$

(0.12)



$

(0.08)



$

(0.13)



$

(0.11)


Adjusted earnings per diluted common share


$

0.09



$

0.26



$

0.22



$

0.38


 

Management defines adjusted net income attributable to AAC Holdings, Inc. common stockholders as net income (loss) attributable to AAC Holdings, Inc. common stockholders adjusted for litigation settlement and California matter related expense, acquisition-related expense (which includes professional services for accounting, legal, valuation services and licensing expenses), de novo start-up and other expenses, recruitment and retention expense, employee severance expense, facility closure operating losses and expense and the income tax effect of the non-GAAP adjustments at the then applicable effective tax rate.

Adjusted diluted earnings per common share represents diluted earnings per common share calculated using adjusted net income attributable to AAC Holdings, Inc. common stockholders as opposed to net income attributable to AAC Holdings, Inc. common stockholders.

Cision View original content:http://www.prnewswire.com/news-releases/aac-holdings-inc-reports-second-quarter-2018-results-300690576.html

SOURCE AAC Holdings, Inc.